论文部分内容阅读
肥厚型心肌病的发生率为0.2%(1∶500),中国人为0.16%。绝大多数患者没有症状,其中25%出现流出道梗阻,仅有约5%～10%的患者药物治疗效果不佳或药物有效剂量引起严重不良反应,需要介入治疗或外科治疗的患者仅占极少部分。乔树宾教授就肥厚梗阻型心肌病(HOCM)的治疗进行了专题报告。乔树宾教授指出,对于有症状的HOCM患者的治疗目的:减轻症状、改善机能和生活质量,尽量延长寿命;减轻流出道压力阶差,改善舒张期充盈。治疗方法上首选药物治疗,但10%的患者症状严重、药物治疗效
The incidence of hypertrophic cardiomyopathy was 0.2% (1: 500), Chinese 0.16%. Most patients have no symptoms, of which 25% have outflow obstruction, only about 5% to 10% of patients with poor drug treatment or drug-effective dose caused serious adverse reactions, requiring interventional or surgical treatment of patients only pole A small part. Professor Qiao Shubin made a special report on the treatment of hypertrophic obstructive cardiomyopathy (HOCM). Professor Qiaobu pointed out that for the treatment of patients with symptomatic HOCM purposes: to reduce symptoms, improve function and quality of life, maximize life expectancy; reduce the outflow tract pressure gradient, improve diastolic filling. The preferred drug treatment of treatment, but 10% of patients with severe symptoms, drug treatment effect